ACRA TARS
$28.27 0.73 2.58%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 22 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

997.95M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

803.22M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

-
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

35.30M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

-

Upcoming events

All events
No upcoming events scheduled

Stock chart

Stock analysis

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

-6.73 -
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

5.07 3.31
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

-5.19 -
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

1.26 -
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

-53.85 -

Price change per year

18.40$ 63.69$
Min Max

Summary analysis

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure

Revenue and net income

All parameters

Stock news

All news

The E2E International 100 track 2024

CharterSync’s journey: from startup to global air cargo leader

Планирование на перспективу запустят в федеральной системе северного завоза

Минцифры РФ поддерживает законопроект об упрощении размещения объектов связи вдоль дорог

Президент Эстонии подписал законопроект о конфискации активов РФ

Кремль не видит опасности для турпотока на Кубань из-за обстрелов ВСУ - Песков

PRECIOUS-Золото в минусе в преддверии американской статистики

Европейский X 600 идет вверх после серии стаданных

Цены на газ в Европе растут несмотря на тепло, обильные поставки

Минцифры РФ изучит вопрос с региональными актами по установке базовых станций

Молдавия увеличивает чрезвычайные запасы газа до 10 дней потребления - министр

Минцифры РФ прорабатывает вопрос льготного кредитования операторов на модернизацию сети

В Перми к 2033 году появится крупнейший в России цифровой микрорайон

"Рускон" запустит прямой сервис доставки сборных грузов из Индии в Россию

ВТБ выдал свою первую ипотеку в Крыму

Novabev Group в 8 раз увеличит число своих акций без их дробления

Транснефть нарастила чистую прибыль акционеров по МСФО в 1 кв на 3,8% г/г

Элемент провел IPO по нижней границе диапазона, привлечет 15 млрд р

МИНЦИФРЫ РФ ПРОРАБАТЫВАЕТ ВОПРОС ЛЬГОТНОГО КРЕДИТОВАНИЯ ОПЕРАТОРОВ СВЯЗИ НА МОДЕРНИЗАЦИЮ СЕТИ - МИНИСТР

About company

Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase IIb/III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. The company is also developing TP-04 for the treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.
Address:
15440 Laguna Canyon Road, Irvine, CA, United States, 92618
Company name:
Issuer ticker: TARS
ISIN: US87650L1035
Country: USA
Exchange: ACRA
Currency: $
IPO date: 2020-10-16
Sector: Healthcare
Industry: Biotechnology
Site: https://www.tarsusrx.com

On which stock exchange are (TARS) stocks traded?

(TARS) stocks are traded on ACRA.

What is the ticker of stocks (TARS)?

The stock ticker of ’s stocks or in other words, the code is TARS. The stocks are currently listed on the ACRA exchange.

In which sector and industry does (TARS) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, (TARS) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are (TARS) stocks traded?

(TARS) stocks are traded on the ACRA exchange in dollars.

What is the price of (TARS) stocks today?

The current price of stocks on 30.05.2024 is 28.27 dollars. per share.

What is the dynamics of (TARS) stocks from the beginning of the year?

(TARS) quotes have increased by 0% from the beginning of the year up to 28.27 dollars. per 1 stocks.

How much did (TARS) stocks increase in may 2024?

This month (TARS) quotes have increased by 0% to 28.27 dollars. per share.

How much are (TARS) stocks worth?

Today, on October, 30.05.2024 ’s (TARS) stocks cost 28.27 dollars..

What is the market capitalization of (TARS)?

Capitalization is the market value of (TARS) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 30.05.2024, the market capitalization of (TARS) is estimated at about 997949517 dollars.